1. Tumor-infiltrating γδ T cells as targets of immune checkpoint blockade in melanoma
- Author
-
Di Simone, Marta, Corsale, Anna Maria, Toia, Francesca, Shekarkar Azgomi, Mojtaba, Di Stefano, Anna Barbara, Lo Presti, Elena, Cordova, Adriana, Montesano, Luigi, Dieli, Francesco, and Meraviglia, Serena
- Abstract
Melanoma is one of the most sensitive tumors to immune modulation, and the major challenge for melanoma patients’ survival is immune checkpoint inhibitor (ICI) therapy. γδ T lymphocytes play an antitumoral role in a broad variety of tumors including melanoma and they are optimal candidates for cellular immunotherapy. Thus, a comprehensive analysis of the correlation between γδ T cells and immune checkpoint receptors in the context of melanoma was conducted, with the aim of devising an innovative combined immunotherapeutic strategy. In this study, using the GEPIA2.0 database, a significant positive correlation was observed between the expression of γδ T cell–related genes (TRGC1, TRGC2, TCRD) and immune checkpoint genes (PDCD1, HAVCR2, LAG3), highlighting the potential role of γδ T cells in the immune response within melanoma. Moreover, flow cytometry analysis unveiled a significant augmentation in the population of γδ T cells within melanoma lesions, which exhibited the expression of immune checkpoint receptors including LAG3, TIM3, and PD1. Analysis of single-cell RNA sequencing data revealed a significant enrichment and functional reprogramming of γδ T cell clusters in response to ICIs. Interestingly, the effects of ICI therapy varied between Vδ1 and Vδ2 γδ T cell subsets, with distinct changes in gene expression patterns. Last, a correlation analysis between γδ T cell abundance, immune checkpoint gene expression, and clinical outcomes in melanoma patients showed that low expression of immune checkpoint genes, including LAG3, HAVCR2, and PDCD1, was associated with improved 1-year overall survival, emphasizing the significance of these genes in predicting patient outcomes, potentially outweighing the impact of γδ T cell abundance. This study offers critical insights into the dynamic interaction between γδ T cells, immune checkpoint receptors, and melanoma, providing valuable perspectives for potential therapeutic avenues and predictive markers in this intricate interplay.A comprehensive analysis exploring the intricate correlation between γδ T cells and immune checkpoint receptors in melanoma is the focus of this study. Our findings provide a solid foundation for further exploration, suggesting the strategic combination of adoptive transfer or in vivo activation of γδ T cells with immune checkpoint inhibitor therapy as a compelling approach to enhance anti-tumor responses.
- Published
- 2024
- Full Text
- View/download PDF